CJC-1295 raises growth hormone and IGF-1 — that much is real. But we already know what happens when you directly administer growth hormone to replete adults: underwhelming results. An indirect releaser is unlikely to produce dramatically different outcomes, and the clinical evidence to prove otherwise simply doesn't exist.